A structural equation modeling approach to the concepts of adherence and readiness in antiretroviral treatment

Patient Education and Counseling

Volumn 67, Issue 1-2, 2007, Pages 108-116

  Södergård, Björn ^a   Höfer, Stefan ^b   Halvarsson, Margit ^c   Sönnerborg, Anders ^c   Tully, Mary Patricia ^a,d   Lindblad, Åsa Kettis ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Acquired immunodeficiency syndrome; Highly active antiretroviral therapy; HIV; Patient compliance; Readiness; Sweden

Indexed keywords

ADULT; ARTICLE; BEHAVIOR CHANGE; CHI SQUARE TEST; CONCEPT FORMATION; CONTINGENT NEGATIVE VARIATION; FEMALE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; STRUCTURAL EQUATION MODELING; SWEDEN; THEORY VALIDATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MODELS, PSYCHOLOGICAL; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; REPRODUCIBILITY OF RESULTS; SWEDEN;

EID: 34249951278     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2007.02.010     Document Type: Article

References (53)

1. Stockwell Morris L., and Schultz R.M. Patient compliance-an overview. J Clin Pharm Ther 17 (1992) 283-295
2. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS 17 (2003) 169-177
3. Turner B.J. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis 185 (2002) S143-S151
4. Paterson D.L., Swindells S., Mohr J., Brester M., Vergis E.N., Squier C., Wagener M.M., and Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 133 (2000) 21-30
5. Little S.J., Holte S., Routy J.P., Daar E.S., Markowitz M., Collier A.C., Koup R.A., Mellors J.W., Connick E., Conway B., Kilby M., Wang L., Whitcomb J.M., Hellmann N.S., and Richman D.D. Antiretroviral-drug resistance among patients recently infected with HIV. New Engl J Med 347 (2002) 385-394
6. Torti C., Bono L., Gargiulo F., Uccelli M.C., Quiros-Roldan E., Patroni A., Paraninfo G., Tirelli V., Manca N., De Francesco M.A., Perandin F., and Carosi G. Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naive for anti-retrovirals. Clin Microbiol Infect 10 (2004) 826-830
7. Puig T., Perez-Olmeda M., Rubio A., Ruiz L., Briones C., Franco J.M., Gomez-Cano M., Stuyver L., Zamora L., Alvarez C., Leal M., Clotet B., and Soriano V. Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group. AIDS 14 (2000) 727-732
8. Weinstock H.S., Zaidi I., Heneine W., Bennett D., Garcia-Lerma J.G., Douglas Jr. J.M., LaLota M., Dickinson G., Schwarcz S., Torian L., Wendell D., Paul S., Goza G.A., Ruiz J., Boyett B., and Kaplan J.E. The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. J Infect Dis 189 (2004) 2174-2180
9. Glass T.R., De Geest S., Weber R., Vernazza P.L., Rickenbach M., Furrer H., Bernasconi E., Cavassini M., Hirschel B., Battegay M., and Bucher H.C. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acq Immun Def Synd 41 (2006) 385-392
10. Carrieri M.P., Leport C., Protopopescu C., Cassuto J.P., Bouvet E., Peyramond D., Raffi F., Moatti J.P., Chene G., and Spire B. Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. J Acq Immun Def Synd 41 (2006) 477-485
11. Wagner G.J. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STDS 16 (2002) 599-608
12. Kleeberger C.A., Buechner J., Palella F., Detels R., Riddler S., Godfrey R., and Jacobson L.P. Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS 18 (2004) 683-688
13. Gordillo V., Del Amo J., Soriano V., and Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 13 (1999) 1763-1769
14. Bangsberg D.R., Charlebois E.D., Grant R.M., Holodniy M., Deeks S.G., Perry S., Conroy K.N., Clark R., Guzman D., Zolopa A., and Moss A. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS 17 (2003) 1925-1932
15. Golin C.E., Liu H., Hays R.D., Miller L.G., Beck C.K., Ickovics J., Kaplan A.H., and Wenger N.S. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 17 (2002) 756-765
16. Cook R.L., Sereika S.M., Hunt S.C., Woodward W.C., Erlen J.A., and Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med 16 (2001) 83-88
17. Stein M.D., Rich J.D., Maksad J., Chen M.H., Hu P., Sobota M., and Clarke J. Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use. Am J Drug Alcohol Ab 26 (2000) 195-205
18. Beach M.C., Keruly J., and Moore R.D. Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?. J Gen Intern Med 21 (2006) 661-665
19. Schneider J., Kaplan S.H., Greenfield S., Li W., and Wilson I.B. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 19 (2004) 1096-1103
20. Horne R., Buick D., Fisher M., Leake H., Cooper V., and Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS 15 (2004) 38-44
21. Blanchard K.A., Morgenstern J., Morgan T.J., Labouvie E., and Bux D.A. Motivational subtypes and continuous measures of readiness for change: concurrent and predictive validity. Psychol Addict Behav 17 (2003) 56-65
22. Rollnick S., Heather N., Gold R., and Hall W. Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. Brit J Addict 87 (1992) 743-754
23. Maisto S.A., Chung T.A., Cornelius J.R., and Martin C.S. Factor structure of the SOCRATES in a clinical sample of adolescents. Psychol Addict Behav 17 (2003) 98-107
24. Fontaine K.R., Cheskin L.J., and Allison D.B. Predicting treatment attendance and weight loss: assessing the psychometric properties and predictive validity of the dieting readiness test. J Pers Assess 68 (1997) 173-183
25. Jordan P.J., Redding C.A., Troop N.A., Treasure J., and Serpell L. Developing a stage of change measure for assessing recovery from anorexia nervosa. Eat Behav 3 (2003) 365-385
26. Dozois D.J., Westra H.A., Collins K.A., Fung T.S., and Garry J.K. Stages of change in anxiety: psychometric properties of the University of Rhode Island Change Assessment (URICA) scale. Behav Res Ther 42 (2004) 711-729
27. Nordqvist O., Sodergard B., Tully M.P., Sonnerborg A., and Lindblad A.K. Assessing and achieving readiness to initiate HIV medication. Patient Educ Couns 62 (2006) 21-30
28. Fowler M.E. Recognizing the phenomenon of readiness: concept analysis and case study. J Assoc Nurses AIDS Care 9 (1998) 72-76
29. Prochaska J.O., and Velicer W.F. The transtheoretical model of health behavior change. Am J Health Promot 12 (1997) 38-48
30. Fleury J.D. Empowering potential: a theory of wellness motivation. Nurs Res 40 (1991) 286-291
31. Nichols S.E. Psychosocial reactions of persons with the acquired immunodeficiency syndrome. Ann Intern Med 103 (1985) 765-767
32. Enriquez M., Lackey N.R., O'Connor M.C., and McKinsey D.S. Successful adherence after multiple HIV treatment failures. J Adv Nurs 45 (2004) 438-446
33. Enriquez M., Gore Jr. P.A., O'Connor M.C., and McKinsey D.S. Assessment of readiness for adherence by HIV-positive males who had previously failed treatment. J Assoc Nurses AIDS Care 15 (2004) 42-49
34. Willey C., Redding C., Stafford J., Garfield F., Geletko S., Flanigan T., Melbourne K., Mitty J., and Caro J.J. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther 22 (2000) 858-871
35. Highstein G.R., Willey C., and Mundy L.M. Development of stage of readiness and decisional balance instruments: tools to enhance clinical decision-making for adherence to antiretroviral therapy. AIDS Behav (2006)
36. Sodergard B., Halvarsson M., Brannstrom J., Sonnerborg A., Tully M.P., and Kettis Lindblad A.M. Willey's two-item readiness assessment used in a Swedish sample of HIV-infected patients with antiretroviral treatment. Eighth international congress on drug therapy in HIV infection. Glasgow, UK (2006)
37. Sodergard B., Halvarsson M., Tully M.P., Mindouri S., Nordstrom M.-L., Lindback S., Sonnerborg A., and Kettis Lindblad A. Adherence to treatment in Swedish HIV-infected patients. J Clin Pharm Ther 31 (2006) 605-616
38. Surveillance Statistics 2003: HIV Infection/AIDS. Swedish Institute for Infectious Disease Control (SMI); 2003 [accessed on 04-09-2004 at: http://www.smittskyddsinstitutet.se/SMItemplates/Article.aspx%3Fid=2834].
39. Byrne B.M. Structural equation modeling with AMOS-basic consepts, applications, and programming (2001), Lawrence Erlbaum Associates Inc. Publishers, Mahwah, New Jersey
40. Morisky D.E., Green L.W., and Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24 (1986) 67-74
41. Sodergard B., Halvarsson M., Lindback S., Sonnerborg A., Tully M.P., and Lindblad A.K. Differences in adherence and motivation to HIV therapy-two independent assessments in 1998 and 2002. Pharm World Sci 28 (2006) 248-256
42. Viswanathan H., Anderson R., and Thomas III J. Nature and correlates of SF-12 physical and mental quality of life components among low-income HIV adults using an HIV service center. Qual Life Res 14 (2005) 935-944
43. Haubrich R.H., Little S.J., Currier J.S., Forthal D.N., Kemper C.A., Beall G.N., Johnson D., Dube M.P., Hwang J.Y., and McCutchan J.A. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS 13 (1999) 1099-1107
44. Singh N., Squier C., Sivek C., Wagener M., Nguyen M.H., and Yu V.L. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 8 (1996) 261-269
45. Hinkin C.H., Hardy D.J., Mason K.I., Castellon S.A., Durvasula R.S., Lam M.N., and Stefaniak M. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 18 (2004) S19-S25
46. Ammassari A., Murri R., Pezzotti P., Trotta M.P., Ravasio L., De Longis P., Lo Caputo S., Narciso P., Pauluzzi S., Carosi G., Nappa S., Piano P., Izzo C.M., Lichtner M., Rezza G., Monforte A., Ippolito G., d'Arminio Moroni M., Wu A.W., and Antinori A. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Imm Defic Syndr 28 (2001) 445-449
47. Moatti J.P., Carrieri M.P., Spire B., Gastaut J.A., Cassuto J.P., and Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 Study Group. AIDS 14 (2000) 151-155
48. Bakken S., Holzemer W.L., Brown M.A., Powell-Cope G.M., Turner J.G., Inouye J., Nokes K.M., and Corless I.B. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care STDS 14 (2000) 189-197
49. Singh N., Berman S.M., Swindells S., Justis J.C., Mohr J.A., Squier C., and Wagener M.M. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 29 (1999) 824-830
50. Spire B., Duran S., Souville M., Leport C., Raffi F., and Moatti J.P. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med 54 (2002) 1481-1496
51. Grimes R.M., and Grimes D.E. Psychological states in HIV disease and the nursing response. J Assoc Nurses AIDS Care 6 (1995) 25-32
52. Bradley-Springer L. Patient education for behavior change: help from the transtheoretical and harm reduction models. J Assoc Nurses AIDS Care 7 (1996) 23-33 [discussion 4-40]
53. Balfour L., Kowal J., Silverman A., Tasca G.A., Angel J.B., Macpherson P.A., Garber G., Cooper C.L., and Cameron D.W. A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Care 18 (2006) 830-838